Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator/Na(+),K(+),2Cl(-) Co-transporter-dependent cystic dilation.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1681/ASN.2006030295PMID 17108316
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ion exchangers mediating NaCl transport in the renal proximal tubule

  2007cited by this paper
• A Regulatory Role of Polycystin-1 on Cystic Fibrosis Transmembrane Conductance Regulator Plasma Membrane Expression

  2006cited by this paper
• Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy

  2006cited by this paper
• Volume progression in polycystic kidney disease.

  2006cited by this paper
• Expression of the basolateral Na-K-Cl cotransporter during mouse nephrogenesis and embryonic development.

  2006cited by this paper
• Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models.

  2006cited by this paper
• Heightened epithelial Na+ channel-mediated Na+ absorption in a murine polycystic kidney disease model epithelium lacking apical monocilia.

  2006cited by this paper
• Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors.

  2006cited by this paper
• New developments in the field of cystic kidney diseases.

  2005cited by this paper
• ADPKD: molecular characterization and quest for treatment

  2005cited by this paper
• Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

  2005cited by this paper
• In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents.

  2005cited by this paper
• Molecular Basis of Autosomal Dominant Polycystic Kidney Disease

  2005cited by this paper
• Calcium restores a normal proliferation phenotype in human polycystic kidney disease epithelial cells.

  2005cited by this paper
• Integration of embryonic stem cells in metanephric kidney organ culture.

  2005cited by this paper
• Calcium Restriction Allows cAMP Activation of the B-Raf/ERK Pathway, Switching Cells to a cAMP-dependent Growth-stimulated Phenotype*

  2004cited by this paper
• Renal epithelial development in organotypic culture

  2004cited by this paper
• Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease

  2004cited by this paper
• The epithelial sodium channel: from molecule to disease.

  2004cited by this paper
• Kidneys sans glomeruli.

  2004cited by this paper
• Renal water reabsorption: a physiologic retrospective in a molecular era.

  2004cited by this paper
• The relationship between cell proliferation, Cl- secretion, and renal cyst growth: a study using CFTR inhibitors.

  2004cited by this paper
• Therapies to Slow Polycystic Kidney Disease

  2004cited by this paper
• Pasteurella multocida toxin as a tool for studying Gq signal transduction.

  2004cited by this paper
• Na transport in autosomal recessive polycystic kidney disease (ARPKD) cyst lining epithelial cells.

  2003cited by this paper
• Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic kidneys.

  2003cited by this paper
• Organ culture of intact metanephric kidneys.

  2003cited by this paper
• Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist

  2003cited by this paper
• Basolateral chloride transporters in autosomal dominant polycystic kidney disease

  2002cited by this paper
• Electrolyte and fluid secretion by cultured human inner medullary collecting duct cells.

  2002cited by this paper
• Efficient generation and mapping of recessive developmental mutations using ENU mutagenesis

  2002cited by this paper
• Return of the secretory kidney.

  2002cited by this paper
• The genetics and physiology of polycystic kidney disease.

  2001cited by this paper
• Generation and phenotype of cell lines derived from CF and non-CF mice that carry the H-2K(b)-tsA58 transgene.

  2001cited by this paper
• Contribution of the Na+-K+-2Cl- cotransporter NKCC1 to Cl- secretion in rat OMCD.

  2001cited by this paper
• cAMP-dependent fluid secretion in rat inner medullary collecting ducts.

  2001cited by this paper
• Changes in the exocrine pancreas secondary to altered small intestinal function in the CF mouse.

  2001cited by this paper
• Role of CFTR in autosomal recessive polycystic kidney disease.

  2001cited by this paper
• Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene

  2001cited by this paper
• The cystic fibrosis transmembrane regulator (CFTR) in the kidney.

  2000cited by this paper
• Polycystin 1 is required for the structural integrity of blood vessels.

  2000cited by this paper
• cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway.

  2000cited by this paper
• CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.

  2000cited by this paper
• Time to treat polycystic kidney diseases like the neoplastic disorders that they are.

  2000cited by this paper
• Molecular basis of autosomal dominant polycystic kidney disease.

  1999cited by this paper
• Cystic Fibrosis Transmembrane Conductance Regulator in the Kidney: Clues to Its Role?

  1999cited by this paper
• Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes

  1999cited by this paper
• Origins and formation of microvasculature in the developing kidney.

  1998cited by this paper
• Epithelial transport in polycystic kidney disease.

  1998cited by this paper
• PKD and CF: an interesting family provides insight into the molecular pathophysiology of polycystic kidney disease.

  1998cited by this paper
• Cystic fibrosis and the phenotypic expression of autosomal dominant polycystic kidney disease.

  1998cited by this paper
• Chloride and fluid secretion in polycystic kidney disease.

  1998cited by this paper
• Somatic inactivation of Pkd2 results in polycystic kidney disease.

  1998cited by this paper
• CFTR mRNA and its truncated splice variant (TRN‐CFTR) are differentially expressed during collecting duct ontogeny

  1998cited by this paper
• Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation

  1997cited by this paper
• A synthetic peptide derived from glycine-gated Cl- channel induces transepithelial Cl- and fluid secretion.

  1997cited by this paper
• Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.

  1997cited by this paper
• Organic anion secretion in polycystic kidney disease.

  1997cited by this paper
• Cystic fibrosis transmembrane conductance regulator (CFTR) and renal function.

  1997cited by this paper
• A role for CFTR in human autosomal dominant polycystic kidney disease.

  1996cited by this paper
• The cystic fibrosis transmembrane conductance regulator mediates transepithelial fluid secretion by human autosomal dominant polycystic kidney disease epithelium in vitro.

  1996cited by this paper
• Mechanism of fluid secretion common to aglomerular and glomerular kidneys.

  1996cited by this paper
• Chloride and fluid secretion by cultured human polycystic kidney cells.

  1996cited by this paper
• Erratum: A role for CFTR in human autosomal dominant polycystic kidney disease (American Journal of Physiology - Cell Physiology (January 1996) 270:39 (C389-C399))

  1996cited by this paper
• Immunolocalization of ion transport proteins in human autosomal dominant polycystic kidney epithelial cells.

  1996cited by this paper
• Both the wild type and a functional isoform of CFTR are expressed in kidney.

  1996cited by this paper
• Developmental regulation of CFTR expression during human nephrogenesis.

  1996cited by this paper
• Anion secretion by the inner medullary collecting duct. Evidence for involvement of the cystic fibrosis transmembrane conductance regulator.

  1995cited by this paper
• Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells.

  1995cited by this paper
• Origin of the glomerular vasculature in the developing kidney.

  1995cited by this paper
• Specificity of basolateral organic anion exchanger in proximal tubule for cellular and extracellular solutes.

  1992cited by this paper
• Immunocytochemical localization of the cystic fibrosis gene product CFTR.

  1991cited by this paper
• Heparin inhibits Na(+)-H+ exchange in vascular smooth muscle cells.

  1990cited by this paper
• Factors governing sodium and chloride transport across the inner medullary collecting duct.

  1990cited by this paper
• Fluorescein transport in isolated proximal tubules in vitro: epifluorometric analysis.

  1990cited by this paper
• Fluid secretion in glomerular renal proximal tubules of freshwater-adapted fish.

  1988cited by this paper
• Metanephric development in serum-free organ culture

  1982cited by this paper

• Disruption of the human cystin-1 myristoyl-electrostatic switch causes polycystic kidney disease that phenocopies autosomal recessive polycystic kidney disease.

  2026cites this paper
• Pathogenic Pathways and Therapeutic Strategies in Autosomal Dominant Polycystic Kidney Disease (ADPKD)

  2025cites this paper
• Lack of ANKMY2 suppresses kidney cystogenesis in embryonic- and adult-onset polycystic kidney disease

  2025cites this paper
• A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia.

  2025cites this paper
• Cellular signalling

  2025cites this paper
• Kcnn4/KCa3.1 inhibition blunts polycystic kidney disease progression in mouse models

  2025cites this paper
• Genome-Based Advances in Modeling Renal Ciliopathies and Enhancing Patient Care

  2025cites this paper
• Kidney cystogenesis in embryonic- and adult-onset ADPKD is suppressed from lack of adenylyl cyclase targeting to cilia

  2025cites this paper
• Targeting TRPM3 as a potential therapeutic approach for autosomal dominant polycystic kidney disease

  2025cites this paper
• GLPG2737, a CFTR Inhibitor, Prevents Cyst Growth in Preclinical Models of Autosomal Dominant Polycystic Kidney Disease

  2025cites this paper
• Ultrasound imaging based recognition of prenatal anomalies: a systematic clinical engineering review

  2024cites this paper
• Melanin-like nanoparticles slow cyst growth in ADPKD by dual inhibition of oxidative stress and CREB

  2024cites this paper
• EZH2 inhibition or genetic ablation suppresses cyst growth in autosomal dominant polycystic kidney disease

  2024cites this paper
• The anoctamins: Structure and function.

  2024cites this paper
• Notch3 as a novel therapeutic target for the treatment of ADPKD by regulating cell proliferation and renal cyst development.

  2024cites this paper
• Activation of farnesoid X receptor retards expansion of renal collecting duct cells-derived cysts via inhibition of CFTR-mediated Cl- secretion.

  2024cites this paper
• Poly(ADP-Ribose) Polymerase-1 Lacking Enzymatic Activity Is Not Compatible with Mouse Development

  2023cites this paper
• Pathogenic Relationships in Cystic Fibrosis and Renal Diseases: CFTR, SLC26A9 and Anoctamins

  2023cites this paper
• Calcium signaling in polycystic kidney disease- cell death and survival.

  2023cites this paper
• Loss of Polycystin-1 causes cAMP-dependent switch from tubule to cyst formation

  2022cites this paper
• Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease

  2022cites this paper
• Emerging therapies for autosomal dominant polycystic kidney disease with a focus on cAMP signaling

  2022cites this paper
• Small hairpin inhibitory RNA delivery in the metanephric organ culture identifies long noncoding RNA Pvt1 as a modulator of cyst growth.

  2022cites this paper
• Physiology Assays in Human Kidney Organoids.

  2022cites this paper
• c-JUN n-Terminal Kinase (JNK) Signaling in Autosomal Dominant Polycystic Kidney Disease

  2022cites this paper
• Pinostrobin inhibits renal CFTR-mediated Cl- secretion and retards cyst growth in cell-derived cyst and polycystic kidney disease rats.

  2022cites this paper
• Impact of Pals1 on Expression and Localization of Transporters Belonging to the Solute Carrier Family

  2022cites this paper
• Genome-wide screening in human kidney organoids identifies novel aspects of nephrogenesis

  2021cites this paper
• Genome-wide screening in human kidney organoids identifies developmental and disease-related aspects of nephrogenesis.

  2021cites this paper
• A methionine-Mettl3-N6-methyladenosine axis promotes polycystic kidney disease.

  2021cites this paper
• Recent advances in understanding ion transport mechanisms in polycystic kidney disease

  2021cites this paper
• Chloride transport modulators as drug candidates.

  2021cites this paper
• In silico screening and molecular docking study of compounds from Pedalium murex L. with Vasopressin2 receptor target for Autosomal Dominant Polycystic Kidney Disease

  2021cites this paper
• The chloride channel CFTR is not required for cyst growth in an ADPKD mouse model

  2021cites this paper
• Gender-Dependent Phenotype in Polycystic Kidney Disease Is Determined by Differential Intracellular Ca2+ Signals

  2021cites this paper
• Role of oxygen and the HIF-pathway.

  2020cites this paper
• The Polycystins and Polycystic Kidney Disease

  2020cites this paper
• An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs

  2020cites this paper
• Targeting chloride transport in autosomal dominant polycystic kidney disease.

  2020cites this paper
• Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis.

  2020influential citation
• Prostaglandins as potential targets for the treatment of polycystic kidney disease.

  2020cites this paper
• A biomimetic kidney tubule model.

  2020cites this paper
• The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease

  2020cites this paper
• Activation of P-TEFb by cAMP-PKA signaling in autosomal dominant polycystic kidney disease

  2019cites this paper
• Metanephric organ culture.

  2019cites this paper
• In vitro cyst formation of ADPKD cells.

  2019cites this paper
• Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis.

  2018cites this paper
• Ectopic Phosphorylated Creb Marks Dedifferentiated Proximal Tubules in Cystic Kidney Disease.

  2018influential citation
• Loss of Fnip1 alters kidney developmental transcriptional program and synergizes with TSC1 loss to promote mTORC1 activation and renal cyst formation

  2018cites this paper
• A mutation affecting polycystin-1 mediated heterotrimeric G-protein signaling causes PKD

  2018cites this paper
• Metabolism and mitochondria in polycystic kidney disease research and therapy

  2018cites this paper
• Aberrant Cellular Pathways in PKD

  2018cites this paper
• Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease

  2017cites this paper
• Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.

  2017cites this paper
• Primary cilia control the maturation of tubular lumen in renal collecting duct epithelium.

  2017cites this paper
• THE ROLE OF MATRICELLULAR SIGNALING IN POLYCYSTIC KIDNEY DISEASE

  2017cites this paper
• Polycystic Kidney Disease.

  2017cites this paper
• Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation.

  2017cites this paper
• Dibutyryl-cAMP attenuates pulmonary fibrosis by blocking myofibroblast differentiation via PKA/CREB/CBP signaling in rats with silicosis

  2017cites this paper
• Anticystogenic activity of a small molecule PAK4 inhibitor may be a novel treatment for autosomal dominant polycystic kidney disease.

  2017cites this paper
• Overexpression of exogenous kidney-specific Ngal attenuates progressive cyst development and prolongs lifespan in a murine model of polycystic kidney disease.

  2017cites this paper
• Repulsive guidance molecule b inhibits renal cyst development through the bone morphogenetic protein signaling pathway.

  2016cites this paper
• Food Restriction Ameliorates the Development of Polycystic Kidney Disease.

  2016cites this paper
• Phosphodiesterase Isoform Regulation of Cell Proliferation and Fluid Secretion in Autosomal Dominant Polycystic Kidney Disease.

  2016cites this paper
• New Insights into the Molecular Mechanisms Targeting Tubular Channels/Transporters in PKD Development

  2016cites this paper
• Characterisation of pathophysiological function of NEDD4-2 in kidney

  2016cites this paper
• pathwaysmodels via cAMP and EGFR-Src-MEK stimulate fluid secretion and cyst growth of in vitro Endogenous concentrations of ouabain act as a cofactor to

  2016cites this paper
• RAPAMYCIN INCREASES LENGTH AND MECHANOSENSORY FUNCTION OF PRIMARY CILIA IN RENAL EPITHELIAL AND VASCULAR ENDOTHELIAL CELLS

  2016cites this paper
• Chloride secretion by renal collecting ducts

  2015cites this paper
• The Effect of cAMP-PKA Activation on TGF-β1-Induced Profibrotic Signaling

  2015cites this paper
• Ouabain Regulates CFTR-Mediated Anion Secretion and Na,K-ATPase Transport in ADPKD Cells

  2015cites this paper
• Aquaporin‐1 retards renal cyst development in polycystic kidney disease by inhibition of Wnt signaling

  2015cites this paper
• The Future of Polycystic Kidney Disease Research--As Seen By the 12 Kaplan Awardees.

  2015cites this paper
• The Role of Calcium and Cyclic AMP in PKD

  2015cites this paper
• Glucose promotes secretion-dependent renal cyst growth

  2015influential citation
• Polycystic Kidney Disease: A Paradigm in Major Kidney Disorders

  2015cites this paper
• Hypoxia-inducible factor-1α causes renal cyst expansion through calcium-activated chloride secretion.

  2014cites this paper
• Kidney: polycystic kidney disease

  2014cites this paper
• Downregulating hedgehog signaling reduces renal cystogenic potential of mouse models.

  2014cites this paper
• Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.

  2014cites this paper
• A New Therapeutic Strategy for Autosomal Dominant Polycystic Kidney Disease: Activation of AMP Kinase by Metformin

  2014cites this paper
• THE ROLE OF MACROPHAGES IN THE PROGRESSION OF POLYCYSTIC KIDNEY DISEASE

  2014cites this paper
• Hypoxia-Inducible Factor-1a Causes Renal Cyst Expansion through Calcium-Activated Chloride

  2014cites this paper
• Novel Functional Complexity of Polycystin-1 by GPS Cleavage In Vivo: Role in Polycystic Kidney Disease

  2014cites this paper
• Impaired glomerulogenesis and endothelial cell migration in Pkd1-deficient renal organ cultures

  2014cites this paper
• Parasympathetic innervation regulates tubulogenesis in the developing salivary gland.

  2014cites this paper
• Molecular functions of anoctamin 6 (TMEM16F): a chloride channel, cation channel, or phospholipid scramblase?

  2014cites this paper
• Vasopressin-2 receptor signaling and autosomal dominant polycystic kidney disease: from bench to bedside and back again.

  2014cites this paper
• Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells.

  2014cites this paper
• Phosphodiesterase 1A modulates cystogenesis in zebrafish.

  2014cites this paper
• Experimental therapies and ongoing clinical trials to slow down progression of ADPKD.

  2013cites this paper
• Novel effects of ouabain in autosomal dominant polycystic kidney disease cystogenesis

  2013influential citation
• N-acetilcisteína melhora os fenótipos renal e cardíaco e reduz o peso corpóreo em camundongos císticos deficientes em Pkd1

  2013cites this paper
• Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

  2013cites this paper
• Adenylyl cyclase VI mediates vasopressin-stimulated ENaC activity.

  2013cites this paper
• Chapter 80 – Autosomal Dominant Polycystic Kidney Disease

  2013cites this paper
• Loss of the ciliary kinase Nek8 causes left-right asymmetry defects.

  2013cites this paper
• Ex Vivo Modeling of Chemical Synergy in Prenatal Kidney Cystogenesis

  2013cites this paper
• Therapeutic Potential of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Inhibitors in Polycystic Kidney Disease

  2012influential citation
• Calcium ameliorates renal cyst growth in metanephric organ culture: a morphological study.

  2012cites this paper